Johnson & Johnson (JNJ)
(Delayed Data from NYSE)
$146.14 USD
-0.68 (-0.46%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $145.99 -0.15 (-0.10%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth F Momentum D VGM
Industry / Sector Report
Industry : Large Cap Pharmaceuticals
Zacks Industry Rank
Bottom 21% (198 out of 252)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.10 | 2.10 | 9.99 |
Current Quarter Estimate | 2.73 | 37.64 | 60.00 |
Year Ago Quarter Estimate | 2.80 | 11.39 | 52.54 |
Next Quarter Estimate | 2.73 | 34.85 | 61.00 |
Next Year Estimate | 10.93 | 178.47 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 7.36 | 3.90 | 17.08 |
Next Year | 2.63 | 16.10 | 8.00 |
Last 5 Years | 4.20 | 3.00 | 8.10 |
Next 5 Years | 5.70 | 11.90 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 14.04 | 15.53 |
Price/Book (MRQ) | 5.14 | 5.30 |
Price/Cash Flow (MRFY) | 10.74 | 10.16 |
Dividend Yield | 3.24% | 2.85% |
Net Profit Margin (TTM) | 45.26% | 45.26% |
Return on Equity (TTM) | 36.43% | 36.43% |
Debt to Equity (MRQ) | NA | NA |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.